MicroVention Rebrands to Terumo Neuro

September 12, 2024—MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced its rebranding to Terumo Neuro, effective immediately. MicroVention was founded in 1997 and acquired by Terumo Corporation in 2006.

According to the company, this name change signifies a new chapter in the company’s evolution while maintaining its commitment to the creation and commercialization of innovations in neurovascular care.

The company markets more than 30 products for the treatment of cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations. Its products are sold in more than 70 countries through a direct sales organization as well as strategic distribution partnerships.

Terumo Neuro is headquartered in California and has manufacturing facilities in Aliso Viejo, California, and San José, Costa Rica. More information is available online at www.terumoneuro.com.

“This transformation reflects our growth as a company and Terumo’s confidence in our future,” commented Carsten Schroeder, Terumo Neuro’s President and CEO, in the press release. “For 18 years, we have maintained independent branding as MicroVention, and now, as Terumo Neuro, we’re combining the best of MicroVention with the full strength and support of the Terumo family. Our culture, speed of innovation, focus on game-changing technologies, and close collaboration with physicians will remain unchanged.”

Schroeder continued, “What will evolve is a deeper partnership with Terumo, a new visual brand, and a more defined brand identity under our new name and slogan, ‘Terumo Neuro: Game-Changing Impact.’ Our strategy is expanding beyond our core focus on hemorrhagic and ischemic stroke and access solutions to encompass the neurovascular patient care continuum.”